Literature DB >> 15222021

Biological functions of melanoma-associated antigens.

Jiang Xiao1, Hong-Song Chen.   

Abstract

To date, dozens of melanoma-associated antigens (MAGEs) have been identified and classified into 2 subgroups, I and II. Subgroup I consists of antigens which expression is generally restricted to tumor or germ cells, also named as cancer/testis (CT) antigen. Proteins and peptides derived from some of these antigens have been utilized in promising clinical trials of immunotherapies for gastrointestinal carcinoma, esophageal carcinoma, pulmonary carcinoma and so on. Various MAGE family members play important physiological and pathological roles during embryogenesis, germ cell genesis, apoptosis, etc. However, little is known regarding the role of MAGE family members in cell activities. It is reasonable to speculate that the genes for subgroup I MAGEs, which play important roles during embryogenesis, could be later deactivated by a genetic mechanism such as methylation. In the case of tumor formation, these genes are reactivated and the resultant proteins may be recognized and attacked by the immune system. Thus, the subgroup I MAGEs may play important roles in the immune surveillance of certain tumor types. Here, we review the classifications of MAGE family genes and what is known of their biological functions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15222021      PMCID: PMC4572215          DOI: 10.3748/wjg.v10.i13.1849

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  69 in total

1.  An abundance of X-linked genes expressed in spermatogonia.

Authors:  P J Wang; J R McCarrey; F Yang; D C Page
Journal:  Nat Genet       Date:  2001-04       Impact factor: 38.330

2.  A RING finger protein Praja1 regulates Dlx5-dependent transcription through its ubiquitin ligase activity for the Dlx/Msx-interacting MAGE/Necdin family protein, Dlxin-1.

Authors:  Aya Sasaki; Yoshiko Masuda; Kazuhiro Iwai; Kyoji Ikeda; Ken Watanabe
Journal:  J Biol Chem       Date:  2002-04-16       Impact factor: 5.157

3.  Expression pattern and further characterization of human MAGED2 and identification of rodent orthologues.

Authors:  K Langnaese; D U Kloos; M Wehnert; B Seidel; P Wieacker
Journal:  Cytogenet Cell Genet       Date:  2001

4.  Mage-b4, a novel melanoma antigen (MAGE) gene specifically expressed during germ cell differentiation.

Authors:  C Osterlund; V Töhönen; K O Forslund; K Nordqvist
Journal:  Cancer Res       Date:  2000-02-15       Impact factor: 12.701

5.  Novel insights into the INK4-CDK4/6-Rb pathway: counter action of gankyrin against INK4 proteins regulates the CDK4-mediated phosphorylation of Rb.

Authors:  Junan Li; Ming-Daw Tsai
Journal:  Biochemistry       Date:  2002-03-26       Impact factor: 3.162

6.  Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.

Authors:  Robert L Strausberg; Elise A Feingold; Lynette H Grouse; Jeffery G Derge; Richard D Klausner; Francis S Collins; Lukas Wagner; Carolyn M Shenmen; Gregory D Schuler; Stephen F Altschul; Barry Zeeberg; Kenneth H Buetow; Carl F Schaefer; Narayan K Bhat; Ralph F Hopkins; Heather Jordan; Troy Moore; Steve I Max; Jun Wang; Florence Hsieh; Luda Diatchenko; Kate Marusina; Andrew A Farmer; Gerald M Rubin; Ling Hong; Mark Stapleton; M Bento Soares; Maria F Bonaldo; Tom L Casavant; Todd E Scheetz; Michael J Brownstein; Ted B Usdin; Shiraki Toshiyuki; Piero Carninci; Christa Prange; Sam S Raha; Naomi A Loquellano; Garrick J Peters; Rick D Abramson; Sara J Mullahy; Stephanie A Bosak; Paul J McEwan; Kevin J McKernan; Joel A Malek; Preethi H Gunaratne; Stephen Richards; Kim C Worley; Sarah Hale; Angela M Garcia; Laura J Gay; Stephen W Hulyk; Debbie K Villalon; Donna M Muzny; Erica J Sodergren; Xiuhua Lu; Richard A Gibbs; Jessica Fahey; Erin Helton; Mark Ketteman; Anuradha Madan; Stephanie Rodrigues; Amy Sanchez; Michelle Whiting; Anup Madan; Alice C Young; Yuriy Shevchenko; Gerard G Bouffard; Robert W Blakesley; Jeffrey W Touchman; Eric D Green; Mark C Dickson; Alex C Rodriguez; Jane Grimwood; Jeremy Schmutz; Richard M Myers; Yaron S N Butterfield; Martin I Krzywinski; Ursula Skalska; Duane E Smailus; Angelique Schnerch; Jacqueline E Schein; Steven J M Jones; Marco A Marra
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-11       Impact factor: 11.205

7.  Sequential changes in hepatocarcinogenesis induced by diethylnitrosamine plus thioacetamide in Fischer 344 rats: induction of gankyrin expression in liver fibrosis, pRB degradation in cirrhosis, and methylation of p16(INK4A) exon 1 in hepatocellular carcinoma.

Authors:  T J Park; H S Kim; K H Byun; J J Jang; Y S Lee; I K Lim
Journal:  Mol Carcinog       Date:  2001-03       Impact factor: 4.784

8.  Cloning and analysis of MAGE-1-related genes.

Authors:  M Ding; R J Beck; C J Keller; R G Fenton
Journal:  Biochem Biophys Res Commun       Date:  1994-07-15       Impact factor: 3.575

9.  Identification of genes expressed in the amygdala during the formation of fear memory.

Authors:  O Stork; S Stork; H C Pape; K Obata
Journal:  Learn Mem       Date:  2001 Jul-Aug       Impact factor: 2.460

10.  A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.

Authors:  P van der Bruggen; C Traversari; P Chomez; C Lurquin; E De Plaen; B Van den Eynde; A Knuth; T Boon
Journal:  Science       Date:  1991-12-13       Impact factor: 47.728

View more
  21 in total

1.  Expression of MAGE-A1 mRNA is associated with gene hypomethylation in hepatocarcinoma cell lines.

Authors:  Jiang Xiao; Hong-Song Chen; Ran Fei; Xu Cong; Li-ping Wang; Yan Wang; Dong Jiang; Lai Wei; Yu Wang
Journal:  J Gastroenterol       Date:  2005-07       Impact factor: 7.527

2.  miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma.

Authors:  Shyamal D Weeraratne; Vladimir Amani; Adrianne Neiss; Natalia Teider; Deborah K Scott; Scott L Pomeroy; Yoon-Jae Cho
Journal:  Neuro Oncol       Date:  2010-12-22       Impact factor: 12.300

3.  Serum levels of ANOS1 serve as a diagnostic biomarker of gastric cancer: a prospective multicenter observational study.

Authors:  Mitsuro Kanda; Yun-Suhk Suh; Do Joong Park; Chie Tanaka; Sang-Hoon Ahn; Seong-Ho Kong; Hyuk-Joon Lee; Daisuke Kobayashi; Michitaka Fujiwara; Hideaki Shimada; BeLong Cho; Kenta Murotani; Hyung-Ho Kim; Han-Kwang Yang; Yasuhiro Kodera
Journal:  Gastric Cancer       Date:  2019-08-03       Impact factor: 7.370

4.  Mapping of NRAGE domains reveals clues to cell viability in BMP signaling.

Authors:  Jennifer A Rochira; Rebecca A Cowling; Joshua S Himmelfarb; Tamara L Adams; Joseph M Verdi
Journal:  Apoptosis       Date:  2010-01       Impact factor: 4.677

5.  Impact of MAGE-A antigens on taxane response in oral squamous cell carcinoma.

Authors:  Urs D A Müller-Richter; Albert Dowejko; Oliver Driemel; Tobias Reuther; Torsten E Reichert; Alexander C Kübler
Journal:  Oncol Lett       Date:  2010-01-01       Impact factor: 2.967

6.  EBNA3C can modulate the activities of the transcription factor Necdin in association with metastasis suppressor protein Nm23-H1.

Authors:  Rajeev Kaul; Masanao Murakami; Ke Lan; Tathagata Choudhuri; Erle S Robertson
Journal:  J Virol       Date:  2008-12-30       Impact factor: 5.103

7.  MAGE-B2 autoantibody: a new biomarker for pediatric systemic lupus erythematosus.

Authors:  Alice D C Hoftman; Lei-Qian Tai; Sheila Tze; David Seligson; Richard A Gatti; Deborah K McCurdy
Journal:  J Rheumatol       Date:  2008-11-01       Impact factor: 4.666

8.  Adenovirus-mediated delivery of CALR and MAGE-A3 inhibits invasion and angiogenesis of glioblastoma cell line U87.

Authors:  Xin-Li Liu; Dan Zhao; Da-Peng Sun; Yang Wang; Yan Li; Feng-Qi Qiu; Ping Ma
Journal:  J Exp Clin Cancer Res       Date:  2012-02-01

9.  Differential 14-3-3 affinity capture reveals new downstream targets of phosphatidylinositol 3-kinase signaling.

Authors:  Fanny Dubois; Franck Vandermoere; Aurélie Gernez; Jane Murphy; Rachel Toth; Shuai Chen; Kathryn M Geraghty; Nick A Morrice; Carol MacKintosh
Journal:  Mol Cell Proteomics       Date:  2009-08-01       Impact factor: 5.911

10.  Centrosomal localisation of the cancer/testis (CT) antigens NY-ESO-1 and MAGE-C1 is regulated by proteasome activity in tumour cells.

Authors:  Anna Pagotto; Otavia L Caballero; Norbert Volkmar; Sylvie Devalle; Andrew J G Simpson; Xin Lu; John C Christianson
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.